Intranodular Thyroid Metastasis of a Large Cell Neuroendocrine Carcinoma of the Endometrium

A 64-year-old woman underwent initial 18 F-FDG PET/CT staging for a suspicious endometrial mass, which showed high uptake in the endometrial mass and a focal uptake in a known left thyroid nodule. Histology revealed a high-grade large cell neuroendocrine carcinoma of the endometrium with FIGO (International Federation of Gynecology and Obstetrics) stage Ib. Further explorations revealed a synchronous thyroid metastasis. Patient then received adjuvant immunochemotherapy. This case showed a potential pitfall in the initial assessment of this rare and aggressive malignancy on which the therapeutic approach greatly depends.

Authors

Institutions

Publication Details

Journal
Clinical Nuclear Medicine
Published
2025-01-09
DOI
https://doi.org/10.1097/rlu.0000000000005665
Citations
1
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intranodular Thyroid Metastasis of a Large Cell Neuroendocrine Carcinoma of the Endometrium

Vincent Cockenpot, S. Hescot, Virginie Huchet, Abir Al Ghuzlan et al.
1 citations
Clinical Nuclear Medicine
Neuroendocrine Tumor Research Advances
1.35
article

Intranodular Thyroid Metastasis of a Large Cell Neuroendocrine Carcinoma of the Endometrium

Vincent Cockenpot, S. Hescot, Virginie Huchet, Abir Al Ghuzlan, Capucine Richard
article en
1 citations

Abstract

A 64-year-old woman underwent initial 18 F-FDG PET/CT staging for a suspicious endometrial mass, which showed high uptake in the endometrial mass and a focal uptake in a known left thyroid nodule. Histology revealed a high-grade large cell neuroendocrine carcinoma of the endometrium with FIGO (International Federation of Gynecology and Obstetrics) stage Ib. Further explorations revealed a synchronous thyroid metastasis. Patient then received adjuvant immunochemotherapy. This case showed a potential pitfall in the initial assessment of this rare and aggressive malignancy on which the therapeutic approach greatly depends.

Clinical Nuclear MedicineVol. 50(6)
Institut Gustave Roussy (FR), Institut Curie (FR)
Good health and well-being
Openalex Percentile: Top 24%
Neuroendocrine Tumor Research Advances
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.